The US Food and Drug Administration will be looking soon for 10 manufacturers with problematic compliance histories to volunteer to play in a pilot program to improve the quality and maturity of their manufacturing organizations – and clean up their compliance issues along the way.
Launching in 2020, the voluntary pilot – colloquially known as the Noncompliant Site Voluntary Improvement Program (NSC VIP) – will be modeled on the agency’s burgeoning Case for Quality...
CFQ VIP is run jointly by the agency and the Medical Device Innovation Consortium (MDIC). It aims to elevate product, manufacturing and process quality at device firms by appraising the...